Management of Atrophic Rhinitis
The cornerstone of atrophic rhinitis management is continuous nasal hygiene with saline or sodium bicarbonate irrigations combined with periodic crust debridement, with topical or systemic antibiotics reserved for purulent secretions or acute infection. 1
Understanding Atrophic Rhinitis
Atrophic rhinitis presents as a chronic condition with progressive nasal mucosal atrophy, characterized by:
- Nasal crusting, dryness, and foul odor (fetor) due to glandular cell atrophy 1
- Abnormally wide nasal cavities on examination with absent or atrophic turbinates ("empty nose syndrome" on CT) 1
- Paradoxical severe nasal congestion despite reduced tissue and increased airflow resistance 1
Primary vs. Secondary Forms
Primary (idiopathic) atrophic rhinitis is more prevalent in developing countries with warm climates, predominantly affects young to middle-aged women, and involves bacteria such as Klebsiella ozaenae, S. aureus, Proteus mirabilis, and E. coli (though causation versus secondary infection remains unclear) 1, 2
Secondary atrophic rhinitis results from chronic granulomatous disorders, chronic sinusitis, excessive nasal turbinate surgery, trauma, or irradiation, and tends to be less severe and progressive 1
Treatment Algorithm
First-Line Conservative Management
Continuous nasal hygiene is the mainstay of treatment for both primary and secondary atrophic rhinitis: 1
- Intranasal irrigations with saline or sodium bicarbonate solution performed regularly 1
- Periodic debridement of crusts as necessary 1
- Nasal douches and drops (glucose-glycerine, liquid paraffin) for lubrication 3
Antibiotic Therapy
Add topical antibiotics (such as mupirocin) to lavage solution when purulent secretions are present 1
Initiate systemic antibiotics when acute infection develops 1
Additional Conservative Measures
- Hygiene optimization, well-balanced diet, and smoking cessation to prevent disease progression 2
- Early detection and treatment of nasal pathology 2
- Vasodilators and nasal prostheses may be considered in select cases 3
Important Clinical Caveats
There are no controlled trials evaluating therapies for atrophic rhinitis, and published observational data remain limited 1. This lack of high-quality evidence means treatment recommendations are based on expert consensus and clinical experience rather than rigorous comparative studies 3.
Surgical interventions (aimed at decreasing nasal cavity size, promoting mucosal regeneration, or improving vascularity) have been described but lack robust evidence for long-term efficacy 3. A Cochrane review found no RCTs meeting inclusion criteria for surgical or medical interventions with adequate follow-up 3.
Emerging therapies such as platelet-rich plasma (PRP) injection show preliminary promise for tissue regeneration and symptom improvement, but current evidence is compromised by diagnostic uncertainty, methodological inconsistencies, and potential commercial bias 4. Rigorous, independently funded trials are needed before clinical recommendations can be made 4.
When to Refer
Consider specialist consultation when: